作者: Laura Vásquez de Ricciardi , Nelson Vicuña-Fernández , José Vicente Scorza , Libia Vasquez , Yaneira Petit de Peña
DOI:
关键词:
摘要: Chemotherapeutic treatment of cutaneous and visceral leishmaniasis has not seen progress since the time antimony was first used some fifty years ago. Its cost levels toxicity, prolonged duration therapy, individual variations in response to therapy have created need evaluating use other pharmacological options such as: aminoglucoside antibiotics. The antibiotic evaluated both clinica